Amyris

Amyris Current Liabilities

Delisted·May 7, 2024

Current Liabilities of Amyris (AMRSQ) as of Nov 22, 2026.

Current Liabilities

-USD

Last updated:

Current Liabilities of Amyris is 2026 - USD. Current Liabilities of Amyris was 2025 - USD. It decreases by % lower compared to the previous year.

The Amyris Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2011
92.30 M USD
Jan 1, 2012
45.80 M USD
Jan 1, 2013
37.20 M USD
Jan 1, 2014
40.00 M USD
Jan 1, 2015
75.50 M USD
Jan 1, 2016
109.90 M USD
Jan 1, 2017
106.00 M USD
Jan 1, 2018
211.70 M USD
The Amyris Current Liabilities history
YEARCurrent LiabilitiesYoY
211.70 MUSD+99.72%
106.00 MUSD-3.55%
109.90 MUSD+45.56%
75.50 MUSD+88.75%
40.00 MUSD+7.53%
37.20 MUSD-18.78%
45.80 MUSD-50.38%
92.30 MUSD+238.10%
27.30 MUSD+14.71%
23.80 MUSD+176.74%
8.60 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

On Eulerpool you can find the complete historical development of Current Liabilities Amyris since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Amyris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amyris

All Key Metrics — Amyris